Amesh Adalja

George Ferguson discusses Boeing whistleblower report. Mark Bergen on Google's AI strategy. Drew Reading covers Lennar earnings. Amesh Adalja talks about flesh eating bacteria in Japan. Girish Saligram shares Weatherford's post-bankruptcy rebound. Corey Cantor shares BNEF's global EV forecast.

Amesh Adalja, a senior scholar at the Johns Hopkins Center for Health Security, brings his expertise in infectious diseases to the discussion. He explores how war zones can propagate diseases, referencing the historical connection between conflict and pandemics. Topics include the threat of 'Disease X' in current conflicts, the rise of antimicrobial resistance due to wartime conditions, and how disruptions in healthcare amplify risks. Amesh emphasizes the need for better preparedness, warning that political divides could leave us vulnerable to the next outbreak.

Tara Nathan, EVP and Founder of Mastercard’s Community Pass, shares insights on improving access to social services in remote communities in Africa and South Asia. Michael E. Mann, a Professor at the University of Pennsylvania, discusses lessons from his book, stressing urgent climate action informed by historical data. Dr. Amesh Adalja, a Senior Scholar at Johns Hopkins, analyzes the new Covid XEC variant, emphasizing readiness for future outbreaks and targeted vaccinations for high-risk groups, all while navigating ongoing public health challenges.

Experts in aviation, retail, homebuilding, and public health discuss Boeing's production challenges, U.S. consumer behavior amid economic factors, homebuilder strategies, rising cases of a flesh-eating disease in Japan, and a financial executive's journey to the C-Suite.

Amesh Adalja, M.D., is a seasoned expert in infectious disease and pandemic preparedness. He compares COVID-19 to past pandemics like the Spanish flu, discussing its origins and the potential for seasonal recurrence. Amesh sheds light on early modeling errors and critiques government responses during the pandemic. He highlights the importance of effective testing and offers reasons for cautious optimism about future pandemic preparedness. His insights underscore the need for continued engagement and learning from our experiences.